Special Issue on Hemoglobinopathies

Submission Deadline: Feb. 25, 2020

Please click the link to know more about Manuscript Preparation: http://www.ajasr.org/submission

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)
  • Lead Guest Editor
    • Tamer Hassan
      Zagazig University, Zagazig, Egypt
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
    • Galila Mokhtar
      Ain Shams University, Cairo, Egypt
  • Introduction

    Hemoglobinopathies are defined as inherited qualitative or quantitative abnormalities of globin synthesis. Thalassemias are generally caused by inadequate quantities of the polypeptide chains that form hemoglobin and the most frequent forms of thalassemia are therefore the α and β-thalassemias. In Sickle cell Anemia, the E6V (glutammic acid to valine at codon 6) mutation replaces a polar by a neutral amino acid on the outer surface of the b-globin molecule. The red blood cells of people with sickle cell disease contain an abnormal type of hemoglobin, called hemoglobin S. There are also some clinically significant variant hemoglobin including hemoglobin C, hemoglobin E, hemoglobin constant spring, hemoglobin Barts and hemoglobin H.

    Aims and Scope:

    1. Beta thalassemia Major
    2. Non transfusion dependent thalassemias (NTDT) including thalassemia intermedia
    3. Alpha Thalassemia
    4. Sickle cell Anemia
    5. Other structural hemoglobinopathies including and not limited to Hemoglobin C and Hemoglobin E diseases.
    6. Genotype phenotype relationship in thaassemias
    7. Updates in diagnosis of hemoglobinopathies
    8. Updates in treatment of hemoglobinopathies
    9. Genetic diagnosis of hemoglobinopathies
    10. Prenatal and Preimplantation genetic diagnosis
    11. Hematopoietic stem cell transplantation in hemoglobinopathies
    12. Updates in assessment of iron overload in hemoglobinopathies
    13. Updates in ion chelation in hemoglobinopathies

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ajasr.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.